Not applicableStudy completedNCT00524745What this trial is testingImmunogenicity and Reactogenicity of Alternative Schedules of GardasilWho this might be right forDose Schedule Study PATH 903
Large-scale testing (Phase 3)Active Not RecruitingNCT04732871What this trial is testingImmunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 1,720
Large-scale testing (Phase 3)Study completedNCT00696891What this trial is testingStudy Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in AdultsWho this might be right forHepatitis B GlaxoSmithKline 380
Testing effectiveness (Phase 2)Study completedNCT00890877What this trial is testingOC000459 Dose Finding Study in Patients With Mild to Moderate Persistent AsthmaWho this might be right forMild to Moderate Persistent Asthma Oxagen Ltd 480
Early research (Phase 1)Study completedNCT00100672What this trial is testingStudy to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced CancerWho this might be right forNeoplasms INSYS Therapeutics Inc 40
Early research (Phase 1)Study completedNCT01905111What this trial is testingBI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic CancerWho this might be right forNeoplasms Boehringer Ingelheim 21
Early research (Phase 1)Study completedNCT02359344What this trial is testingPK & Tolerability of CNV1014802 in Young and Elderly Healthy VolunteersWho this might be right forTrigeminal Neuralgia Biogen 32
Post-approval studies (Phase 4)Study completedNCT03546634What this trial is testingSero-conversion Study for a Two-dose Schedule of Sabin IPV in ChinaWho this might be right forPoliomyelitis Centers for Disease Control and Prevention, China 280
Testing effectiveness (Phase 2)Looking for participantsNCT07628049What this trial is testingInvestigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older AdultsWho this might be right forRespiratory Syncytial Virus Infections+Metapneumovirus GlaxoSmithKline 1,456
Large-scale testing (Phase 3)Study completedNCT00574548What this trial is testingStudy Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPSWho this might be right forPneumococcal Vaccines Wyeth is now a wholly owned subsidiary of Pfizer 720
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07701941What this trial is testingPatritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast CancerWho this might be right forHormone Receptor PositiveHER2-low or HER2-ultralowUnresectable or Metastatic Breast Cancer Daiichi Sankyo 220
Testing effectiveness (Phase 2)Study completedNCT02740777What this trial is testingEvaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent FemalesWho this might be right forHuman PapillomavirusCervical Intraepithelial NeoplasiaPersistent Infection Shanghai Zerun Biotechnology Co.,Ltd 900
Testing effectiveness (Phase 2)Study completedNCT01977456What this trial is testingStudy of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)Who this might be right forStrokeBrain Infarction Arthur Pancioli 27
Large-scale testing (Phase 3)Study completedNCT00197119What this trial is testingLong-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 YearsWho this might be right forHepatitis BHepatitis A GlaxoSmithKline 244
Early research (Phase 1)Active Not RecruitingNCT07608666What this trial is testingStudy to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 TabletsWho this might be right forMyelofibrosis Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 17
Early research (Phase 1)Study completedNCT04661839What this trial is testingA COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy AdultsWho this might be right forCOVID-19 Emergent BioSolutions 28
Early research (Phase 1)Study completedNCT01132625What this trial is testingDose Escalation Study of AUY922 in Advanced Solid Malignancies in JapanWho this might be right forAdvanced Solid Tumors Novartis Pharmaceuticals 37
Early research (Phase 1)Study completedNCT05723640What this trial is testingThe Safety and Dosimetry Study of 177Lu-LNC1004 InjectionWho this might be right forSolid Tumor, Unspecified, Adult Yantai LNC Biotechnology Singapore PTE. LTD. 11
Early research (Phase 1)Study completedNCT01540526What this trial is testingPharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose AxitinibWho this might be right forSolid MalignanciesMetastatic Castrate-resistant Prostate Cancer University of Wisconsin, Madison 24
Testing effectiveness (Phase 2)Study completedNCT00123565What this trial is testingHexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial InfarctionWho this might be right forCoronary Atherosclerosis Sanofi 1,257